Literature DB >> 2458389

Oxypurine cycle in human erythrocytes regulated by pH, inorganic phosphate, and oxygen.

P A Berman1, D A Black, L Human, E H Harley.   

Abstract

The effect of pH, PO2, and inorganic phosphate on the uptake and metabolism of hypoxanthine by erythrocytes has been studied. Uptake of hypoxanthine and accumulation of inosine 5'-monophosphate (IMP) were markedly increased at acid pH, high external phosphate concentrations, and low PO2. Release of accumulated IMP as hypoxanthine occurred at alkaline pH values and low external phosphate concentrations. Conditions favoring IMP accumulation gave rise, in the absence of hypoxanthine, to a corresponding increase in 5'-phosphoribosyl-1-pyrophosphate. Intracellular phosphate concentrations were markedly pH dependent and a model is presented whereby hypoxanthine uptake and release are controlled by intracellular concentrations of inorganic phosphate and 2,3-bisphosphoglycerate. These allosteric effectors influence, in opposing ways, two enzymes governing IMP accumulation, namely 5'-phosphoribosyl-1-pyrophosphate synthetase and 5'-nucleotidase. These metabolic properties suggest that the erythrocyte could play a role in the removal of hypoxanthine from anoxic tissue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458389      PMCID: PMC303611          DOI: 10.1172/JCI113707

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Enzymatic deficiencies of purine nucleotide synthesis in the human erythrocyte.

Authors:  B A LOWY; M K WILLIAMS; I M LONDON
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

Review 2.  The mechanism of interaction of red cell organic phosphates with hemoglobin.

Authors:  R E Benesch; R Benesch
Journal:  Adv Protein Chem       Date:  1974

3.  Human phosphoribosylpyrophosphate synthetase. Kinetic mechanism and end product inhibition.

Authors:  I H Fox; W N Kelley
Journal:  J Biol Chem       Date:  1972-04-10       Impact factor: 5.157

4.  Human phosphoribosylpyrophosphate synthetase. Distribution, purification, and properties.

Authors:  I H Fox; W N Kelley
Journal:  J Biol Chem       Date:  1971-09-25       Impact factor: 5.157

5.  Studies on erythrocyte glycolysis. 3. The effects of active cation transport, pH and inorganic phosphate concentration on erythrocyte glycolysis.

Authors:  S Minakami; H Yoshikawa
Journal:  J Biochem       Date:  1966-02       Impact factor: 3.387

6.  Regulation of the synthesis of 5-phosphoribosyl-I-pyrophosphate in intact red blood cells and in cell-free preparations.

Authors:  A Hershko; A Razin; J Mager
Journal:  Biochim Biophys Acta       Date:  1969-06-17

7.  The interaction between erythrocyte organic phosphates, magnesium ion, and hemoglobin.

Authors:  H F Bunn; B J Ransil; A Chao
Journal:  J Biol Chem       Date:  1971-09-10       Impact factor: 5.157

8.  Turnover of purine nucleotides in rabbit erythrocytes. II. Studies in vitro.

Authors:  A Hershko; A Razin; T Shoshani; J Mager
Journal:  Biochim Biophys Acta       Date:  1967-11-21

9.  Turnover of purine nucleotides in human red blood cells.

Authors:  J Mager; A Dvilansky; A Razin; E Wind; G Izak
Journal:  Isr J Med Sci       Date:  1966 May-Jun

10.  Hypoxanthine transport in human erythrocytes.

Authors:  U V Lassen
Journal:  Biochim Biophys Acta       Date:  1967-02-01
View more
  7 in total

1.  Pyrimidine 5'-nucleotidase activity in normal and deficient human lymphoblastoid cells.

Authors:  D A Hopkinson; D M Swallow; A Marinaki; E H Harley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Accelerated degradation of adenine nucleotide in erythrocytes of patients with chronic renal failure.

Authors:  M Marlewski; R T Smolenski; M Szolkiewicz; Z Aleksandrowicz; B Rutkowski; J Swierczynski
Journal:  Mol Cell Biochem       Date:  2000-10       Impact factor: 3.396

3.  Adenine, guanine and pyridine nucleotides in blood during physical exercise and restitution in healthy subjects.

Authors:  W Dudzinska; A Lubkowska; B Dolegowska; K Safranow; K Jakubowska
Journal:  Eur J Appl Physiol       Date:  2010-08-17       Impact factor: 3.078

4.  The accumulation of mercaptopurine metabolites in age fractionated red blood cells.

Authors:  A Rostami-Hodjegan; L Lennard; J S Lilleyman
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

5.  Xanthine oxidase inhibits growth of Plasmodium falciparum in human erythrocytes in vitro.

Authors:  P A Berman; L Human; J A Freese
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

6.  Purine salvage pathways among Borrelia species.

Authors:  Jonas Pettersson; Merry E Schrumpf; Sandra J Raffel; Stephen F Porcella; Cyril Guyard; Kevin Lawrence; Frank C Gherardini; Tom G Schwan
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

7.  Comparison of human erythrocyte purine nucleotide metabolism and blood purine and pyrimidine degradation product concentrations before and after acute exercise in trained and sedentary subjects.

Authors:  Wioleta Dudzinska; M Suska; A Lubkowska; K Jakubowska; M Olszewska; K Safranow; D Chlubek
Journal:  J Physiol Sci       Date:  2017-04-21       Impact factor: 2.781

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.